Power Doppler ultrasonography of the feeding arteries of the prostate gland: A novel approach to the diagnosis of prostate cancer?

Journal of Ultrasound in Medicine

Volumn 26, Issue 7, 2007, Pages 875-883

  Turgut, Ahmet Tuncay ^a,d   Ölçücüoǧlu, Esin ^a   Koşar, Pinar ^a   Geyik, Pinar Özdemir ^b   Koşar, Uǧur ^a   Dogra, Vikram ^c  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^d NONE   (Turkey)

Author keywords

Prostate; Prostatic neoplasms; Transrectal color Doppler ultrasonography

Indexed keywords

BIOPSY; DOPPLER EFFECT; PATIENT TREATMENT; TUMORS; ULTRASONOGRAPHY;

MEAN PULSATILITY INDEX VALUES; PROSTATE CANCER; PROSTATIC NEOPLASMS; TRANSRECTAL COLOR DOPPLER ULTRASONOGRAPHY;

BIOLOGICAL ORGANS;

ADULT; AGED; ARTERY; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIASTOLE; DOPPLER FLOWMETRY; FEEDING ARTERY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; PARAMETER; PROSTATE; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; SPECTROSCOPY; STATISTICAL SIGNIFICANCE; SYSTOLE;

EID: 34447130188     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2007.26.7.875     Document Type: Article

References (36)

1. Rifkin MD, Sudakoff GS, Alexander AA. Prostate: techniques, results, and potential applications of color Doppler US scanning. Radiology 1993; 186:509-513.
2. Louvar E, Littrup PJ, Goldstein A, Yu L, Grignon SW. Correlation of color Doppler flow in the prostate with tissue microvascularity. Cancer 1998; 83:135-140.
3. Neumaier CE, Martinoli C, Derchi LE, Silvestri E, Rosenberg I. Normal prostate gland: examination with color Doppler US. Radiology 1995; 196:453-457.
4. Berger AP Deibl M, Leonhartsberger N, et al. Vascular damage as a risk factor for benign prostatic hyperplasia and erectile dysfunction. BJU Int 2005; 96:1073-1078.
5. Keener T, Winter TC, Berger R, et al. Prostate vascular flow: the effect of ejaculation as revealed on transrectal power Doppler sonography. AJR Am J Roentgenol 2000; 175:1169-1172.
6. Rubin JM, Bude RO, Carson PL, Bree RL, Adler RS. Power Doppler US: a potentially useful alternative to mean frequency-based color Doppler US. Radiology 1994; 190: 853-856.
7. Leventis AK, Shariat SF, Utsunomiya T, Slawin KM. Characteristics of normal prostate vascular anatomy as displayed by power Doppler. Prostate 2001; 46:281-288.
8. Bude RO, Rubin JM, Adler RS. Power versus conventional color Doppler sonography: comparison in the depiction of normal intrarenal vasculature. Radiology 1994; 192:777-780.
9. Sadeghi-Nejad H, Simmons M, Dakwar G, Dogra V. Controversies in transrectal ultrasonography and prostate biopsy. Ultrasound Q 2006; 22:169-175.
10. Shinohara K, Wheeler TM, Scardino FT. The appearance of prostate cancer on transrectal ultrasonography: correlation of imaging and pathological examinations. J Urol 1989; 142:76-82.
11. Coley CM, Barry MJ, Fleming C, Mulley AG. Early detection of prostate cancer, part I: prior probability and effectiveness of tests. The American College of Physicians. Ann Intern Med 1997; 126:394-406.
12. Raja J, Ramachandran N, Munneke G, Patel U. Current status of transrectal ultrasound-guided prostate biopsy in the diagnosis of prostate cancer. Clin Radiol 2006; 61:142-153.
13. Purohit RS, Shinohara K, Meng MV, Carroll PR. Imaging clinically localized prostate cancer. Urol Clin North Am 2003; 30:279-293.
14. Brawer MK, Bigler SA, Deering RE. Quantitative morphometric analysis of the microcirculation in prostate carcinoma. J Cell Biochem Suppl 1992; 16:62-64.
15. Bigler SA, Deering RE, Brawer MK. Comparison of microscopic vascularity in benign and malignant prostate tissue. Hum Pathol 1993; 24:220-226.
16. Siegal JA, Yu E, Brawer MK. Topography of neovascularity in human prostate carcinoma. Cancer 1995; 75:2545-2551.
17. Halpern EJ, Strup SE. Using gray-scale and color and power Doppler sonography to detect prostatic cancer. AJR Am J Roentgenol 2000; 174:623-627.
18. Lavoipierre AM, Snow RM, Frydenberg M, et al. Prostatic cancer: role of color Doppler imaging in transrectal sonography. AJR Am J Roentgenol 1998; 171:205-210.
19. Frauscher F, Gradl J, Pallwein L. Prostate ultrasound: for urologists only? Cancer Imaging 2005; 5:76-82.
20. Passavanti G, Pizzuti V, Bragaglia A, Costantini FM, Paolini R. The association of TR systematic echobiopsy of the prostate with power Doppler (PDU) in borderline PSA patients. Arch Ital Urol Androl 2005; 77:40-42.
21. Passavanti G, Pizzuti V. Power Doppler ultrasonography (PDU) as an additional tool to increase reliability of systematic biopsy of the prostate: a brief evaluation. Arch Ital Urol Androl 2004; 76:110-112.
22. Inahara M, Suzuki H, Nakamachi H, et al. Clinical evaluation of transrectal power Doppler imaging in the detection of prostate cancer. Int Urol Nephrol 2004; 36:175-180.
23. Okihara K, Ukimura O, Mizutani Y, Kawauchi A, Nakao M, Miki T Prostate cancer detection using power Doppler imaging. Drugs Today (Barc) 2003; 39:389-398.
24. Remzi M, Dobrovits M, Reissigl A, et al. Can power Doppler enhanced transrectal ultrasound-guided biopsy improve prostate cancer detection on first and repeat prostate biopsy? Eur Urol 2004; 46:451-456.
25. Passavanti G, Pizzuti V, Stumpo M, Paolini R. A more effective TR systematic biopsy of the prostate associated with power Doppler ultrasonography (PDU): technical and morphological aspects. Arch Ital Urol Androl 2005; 77:185-188.
26. Karaman CZ, Unsal A, Akdilli A, Taskin F, Erol H. The value of contrast enhanced power Doppler ultrasonography in differentiating hypoechoic lesions in the peripheral zone of prostate. Eur J Radiol 2005; 54:148-155.
27. Arger PH, Malkowicz SB, VanArsdalen KN, Sehgal CM, Holzer A, Schultz SM. Color and power Doppler sonography in the diagnosis of prostate cancer: comparison between vascular density and total vascularity. J Ultrasound Med 2004; 23:623-630.
28. Boczko J, Messing E, Dogra V. Transrectal sonography in prostate evaluation. Radiol Clin North Am 2006; 44: 679-687.
29. Kurjak A, Shalan H, Kupesic S, et al. Transvaginal colour Doppler sonography in the assessment of pelvic tumour vascularity. Ultrasound Obstet Gynecol 1993; 3:137-154.
30. Obwegeser R, Berghammer P, Lorenz K, Auerbach L, Kubista E. Color Doppler sonography of the lateral thoracic (breast-feeding) arteries: a new approach to the diagnosis of breast disease. Ultrasound Obstet Gynecol 2001; 18: 515-519.
31. Delongchamps NB, Peyromaure M, Dinh-Xuan AT. Role of vascular endothelial growth factor in prostate cancer. Urology 2006; 68:244-248.
32. Berger AP, Horninger W, Kektic J, et al. Vascular resistance in the prostate evaluated by colour Doppler ultrasonography: is benign prostatic hyperplasia a vascular disease? BJU Int 2006; 98:587-590.
33. Özdemir H, Onur R, Bozgeyik Z, Orhan I, Ogras MS, Ogur E. Measuring resistance index in patients with BPH and lower urinary tract symptoms. J Clin Ultrasound 2005; 33:176-180.
34. Tsuru N, Kurita Y, Masuda H, Suzuki K, Fujita K. Role of Doppler ultrasound and resistive index in benign prostatic hypertrophy Int J Urol 2002; 9:427-430.
35. Tsuru N, Kurita Y, Suzuki K, Fujita K. Resistance index in benign prostatic hyperplasia using power Doppler imaging and clinical outcomes after transurethral vaporization of the prostate. Int J Urol 2005; 12:264-269.
36. Kojima M, Ochiai A, Naya Y, Okihara K, Ukimura O, Miki T. Doppler resistive index in benign prostatic hyperplasia: correlation with ultrasonic appearance of the prostate and intravesical obstruction. Eur Urol 2000; 37:436-442.